Phase II Trial of Pharmacogenetic Guided Beta-Blocker Therapy With Bucindolol vs. Metoprolol for the Prevention of Atrial Fibrillation/Flutter in Heart Failure: GENETIC-AF AF Burden Substudy
Publication
, Conference
Piccini, JP; Abraham, WT; Healey, JS; Van Veldhuisen, DJ; Sauer, W; Anand, I; White, M; Wilton, SB; Along, RG; Ziegler, PD; Davis, G ...
Published in: CIRCULATION
2018
Duke Scholars
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
2018
Volume
138
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Piccini, J. P., Abraham, W. T., Healey, J. S., Van Veldhuisen, D. J., Sauer, W., Anand, I., … Connolly, S. (2018). Phase II Trial of Pharmacogenetic Guided Beta-Blocker Therapy With Bucindolol vs. Metoprolol for the Prevention of Atrial Fibrillation/Flutter in Heart Failure: GENETIC-AF AF Burden Substudy. In CIRCULATION (Vol. 138).
Piccini, Jonathan P., William T. Abraham, Jeff S. Healey, Dirk J. Van Veldhuisen, William Sauer, Inder Anand, Michel White, et al. “Phase II Trial of Pharmacogenetic Guided Beta-Blocker Therapy With Bucindolol vs. Metoprolol for the Prevention of Atrial Fibrillation/Flutter in Heart Failure: GENETIC-AF AF Burden Substudy.” In CIRCULATION, Vol. 138, 2018.
Piccini JP, Abraham WT, Healey JS, Van Veldhuisen DJ, Sauer W, Anand I, et al. Phase II Trial of Pharmacogenetic Guided Beta-Blocker Therapy With Bucindolol vs. Metoprolol for the Prevention of Atrial Fibrillation/Flutter in Heart Failure: GENETIC-AF AF Burden Substudy. In: CIRCULATION. 2018.
Piccini, Jonathan P., et al. “Phase II Trial of Pharmacogenetic Guided Beta-Blocker Therapy With Bucindolol vs. Metoprolol for the Prevention of Atrial Fibrillation/Flutter in Heart Failure: GENETIC-AF AF Burden Substudy.” CIRCULATION, vol. 138, 2018.
Piccini JP, Abraham WT, Healey JS, Van Veldhuisen DJ, Sauer W, Anand I, White M, Wilton SB, Along RG, Ziegler PD, Davis G, Dufton C, Marshall D, Bristow MR, Connolly S. Phase II Trial of Pharmacogenetic Guided Beta-Blocker Therapy With Bucindolol vs. Metoprolol for the Prevention of Atrial Fibrillation/Flutter in Heart Failure: GENETIC-AF AF Burden Substudy. CIRCULATION. 2018.
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
2018
Volume
138
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology